Early Detection of Diastolic Dysfunction and the Role of Lifestyle Measures in Its Treatment
NCT ID: NCT00998114
Last Updated: 2016-10-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
9 participants
INTERVENTIONAL
2008-06-30
2011-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Markers of Oxidative Stress Diastolic Dysfunction
NCT00846404
Effects of Nebivolol on Exercise Tolerance and Left Ventricular Systolic and Diastolic Function
NCT01056718
Effect of Beta-blockers on Structural Remodeling and Gene Expression in the Failing Human Heart
NCT01798992
Race, Natriuretic Peptides and Physiological Perturbations
NCT03070184
Pulse Pressure Variation for Prediction of Fluid Responsiveness in Coronary Artery Disease Patients With Diastolic Dysfunction
NCT01819571
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Diastolic dysfunction (DD) accounts for \>50% of all heart failure (DHF) hospitalizations and this number is increasing with age, obesity and diabetes.
There are no proven treatments for DHF apart from blood pressure control.
Aim:
If diagnosed early, is this reversible with lifestyle changes; namely, aerobic exercise and weight reduction?
Methods:
We will screen veterans presenting to the medicine, cardiology and pulmonary services with dyspnea. We will perform echocardiography with Doppler which non-invasively measures cardiac filling and diastolic dysfunction. Treadmill exercise echo will be performed to quantify DD.
Bruce treadmill protocol description/ procedure: Exercise is performed on a treadmill. The test starts at 2.74 km/hr (1.7 mph) and at a gradient (or incline) of 10%. At three minute intervals the incline of the treadmill increases by 2%, and the speed increases as shown in the table below.
Stage Speed (mph) Gradient:
1. 1.7 10
2. 2.5 12
3. 3.4 14
4. 4.2 16
5. 5.0 18
6. 5.5 20
7. 6.0 22
8. 6.5 24
9. 7.0 26
10. 7.5 28
Subject exercise study:
For physical exercise to have a beneficial effect on cardiac function, we suggest the following:
* Type of Exercise
* Walking - outdoors or treadmill
* Running or jogging
* Cycling - outdoors or stationary
Duration of Exercise:
Initial 2-3 minute gradual warm-up period. Roughly 30 minutes of continuous exercise 5 times a week.
Finally a few minutes of gradual cool-down before terminating exercise.
Intensity of Exercise:
Target exercise at a "moderately significant exertion".
We will demonstrate what is adequate in the beginning and periodically throughout the 6 months of the study.
"Maximum age predicted heart rate (MPHR)" is calculated as 220 minus subject's age. Then we would like to sustain roughly about 70 to 85% of MPHR for 25-30 minutes.
"Successful" Exerciser: Subjects who are able to adhere to the required intensity and duration of exercise for the majority (about 75% or more) of the time; averaging 150 minutes/ week on self reporting.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Exercise and diastolic dysfunction
Aerobic exercise for 30-45 minutes five times a week for six months
Exercise
Aerobic exercise for 30-45 minutes five times a week for six months
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Exercise
Aerobic exercise for 30-45 minutes five times a week for six months
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 40-65 years of age
* Sedentary lifestyle (\<150 minutes of exercise/week)
* Echocardiographic evidence of early diastolic dysfunction: mitral E/A \<0.9, OR resting E/E' between 8-15 cm/s, OR post-exercise E/E' \>13 cm/s.
Exclusion Criteria
* Coronary Artery Disease by angiography or evidence of ischemia on a stress test
* Systolic Dysfunction (LV Ejection fraction \<50%)
* Congestive Heart Failure Functional Class III or IV
* Moderate to severe COPD (FEV \<80% predicted)
* Moderate to severe valvular heart disease, except tricuspid regurgitation
* Inability to get heart rate \>/= 85% of maximum predicted heart rate
* Uncontrolled hypertension (systolic BP\>140mmHg, diastolic BP\>90mmHg) despite medical therapy
* On echocardiogram, RV systolic pressure \>60mmHg that suggests severe pulmonary hypertension
* On echocardiogram, left atrial size\> 6.5 cm or left atrial volume \> 35 ml/BSA
40 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Missouri-Columbia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Anand Chockalingam
Prof Assoc, Medicine-Cardiology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Anand Chockalingam, MD
Role: PRINCIPAL_INVESTIGATOR
University of Missouri/Harry S Truman VA Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Harry S Truman Veterans Administration Hospital
Columbia, Missouri, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1115737
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.